Atovaquone NDC 60687-534

NDC codes

FDA NDC Directory

Product NDC (as listed)60687-534Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60687-0534Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60687-534-36	60687053436	2 TRAY in 1 CASE (60687-534-36) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-534-46) / 5 mL in 1 CUP, UNIT-DOSE (60687-534-40)Marketed from Jul 13, 2023
60687-534-78	60687053478	7 TRAY in 1 CASE (60687-534-78) / 6 CUP, UNIT-DOSE in 1 TRAY (60687-534-52) / 5 mL in 1 CUP, UNIT-DOSE (60687-534-40)Marketed from Oct 21, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Atovaquone
Generic name (nonproprietary): atovaquone
Active ingredients: Atovaquone — 750 mg/5mL
Dosage form: Suspension
Route: Oral
Labeler: American Health Packaging
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210692
Marketing start: Oct 21, 2020
Listing expires: Dec 31, 2026
Identifiers: Product ID 60687-534_415fac59-7480-cad1-e063-6394a90ad7baSPL ID 415fac59-7480-cad1-e063-6394a90ad7baSPL set ID 1a8a43a2-bc26-4ee5-aa35-22a5477a7129RxCUI 308429UNII Y883P1Z2LT
Pharmacologic class: Antimalarial; Antiprotozoal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460687053436 followed by a unit qualifier and the quantity

Package 60687-0534-36. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 210692

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210692
Product	Strength	Form · route	Labeler	Product NDC
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	Lupin Pharmaceuticals, Inc.	70748-299
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	ATLANTIC BIOLOGICALS CORP.	17856-0631
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	NorthStar RxLLC	72603-248
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	ATLANTIC BIOLOGICALS CORP.	17856-8631
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	Lohxa	70166-488
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	Camber Pharmaceuticals, Inc.	31722-629